Publications by authors named "Oliver Leib"

Claim this Profile
A
Anti-CD33-antibodies labelled with the alpha-emitter Bismuth-213 kill CD33-positive acute myeloid leukaemia cells specifically by activation of caspases and break radio- and chemoresistance by inhibition of the anti-apoptotic proteins X-linked inhibitor of apoptosis protein and B-cell lymphoma-extra large.
Claudia Friesen, Mareike Roscher, Inis Hormann, Oliver Leib, Sebastian Marx

Eur J Cancer· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted alpha-therapy using [Bi-213]anti-CD20 as novel treatment option for radio- and chemoresistant non-Hodgkin lymphoma cells.
Mareike Roscher, Inis Hormann, Oliver Leib, Sebastian Marx, Josue Moreno

Oncotarget· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis